Rehabilitation of patients with cancer of the respiratory system
Journal Title: OncoReview - Year 2012, Vol 2, Issue 4
Abstract
Many patients with lung cancer have concomitant chronic obstructive pulmonary disease and heart diseases. The planned anticancer therapy should be individualized in relationship of patient’s cardiac and pulmonary condition. Pulmonary rehabilitation is based on evidence, its main aim is to improve the quality of life by increasing physical fitness and optimal pattern of ventilation. It may prevent complications such as hypoxemia, respiratory infections, symptoms related to immobilization during hospitalization. Rehabilitation can be recommended both before and after lung resection. The most effective way to prevent post-operative complications is early respiratory physiotherapy before and after surgery. Properly rehabilitation can also be very useful in patients treated with palliative radio- or chemotherapy. The article is a summary of the available results and efficiency of the rehabilitation in patients with lung cancer.
Authors and Affiliations
Oliwia Głogowska, Sebastian Szmit, Maciej Głogowski
Keywords
Related Articles
- EP ID EP53179
- DOI -
- Views 229
- Downloads 0
Early molecular response as a criterion of optimal response to chronic myeloid leukemia treatment with tyrosine kinase inhibitors
Maximal reduction of leukemic BCR/ABL-positive cells and achievement of persistent deep molecular response with the chance for sustained treatment-free survival in possibly all patients is a current goal of chronic myelo...
Terapia ewerolimusem u pacjenta z zaawansowanym nowotworem neuroendokrynnym trzustki – opis przypadku
Coraz częstsze występowanie nowotworów neuroendokrynnych przewodu pokarmowego jest spowodowane nie tylko rzeczywistym wzrostem zachorowalności, ale także postępem w zakresie ich diagnostyki. Właściwe rozpoznanie oraz oce...
Zaawansowany mięsak maziówkowy o długotrawałym przebiegu - opis przypadku i przegląd pismiennictwa
Postęp w leczeniu systemowym przerzutowego raka nerki związany jest z rejestracją nowych leków. Przyniosło to poprawę wyników leczenia, ale zmusza również do dokonywania wyboru leku. Decyzja ta jest szczególnie istotna w...
Exemestan in breast cancer treatment
Hormonotherapy is one of the most important therapeutic options in the breast cancer treatment, either locally advanced or metastatic. Tamoxifen has been standard of care for many years, however new clinical trials resul...
Acromegaly: the effect of somatostatin analogues on tumour volume shrinkage
Acromegaly is a rare disease, caused by growth hormone (GH) hypersecretion and secondarily elevated insulin-like growth hormone 1 (IGF-1) level. Nearly all patients with acromegaly suffer from somatotroph pituitary adeno...